rs376907511
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM1BP4_ModerateBS2_Supporting
The NM_002769.5(PRSS1):āc.541A>Gā(p.Ser181Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000041 in 1,461,874 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S181N) has been classified as Benign.
Frequency
Consequence
NM_002769.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRSS1 | NM_002769.5 | c.541A>G | p.Ser181Gly | missense_variant | 4/5 | ENST00000311737.12 | NP_002760.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRSS1 | ENST00000311737.12 | c.541A>G | p.Ser181Gly | missense_variant | 4/5 | 1 | NM_002769.5 | ENSP00000308720.7 | ||
PRSS1 | ENST00000486171.5 | c.583A>G | p.Ser195Gly | missense_variant | 5/6 | 5 | ENSP00000417854.1 | |||
PRSS1 | ENST00000492062.1 | c.391A>G | p.Ser131Gly | missense_variant | 3/4 | 2 | ENSP00000419912.2 | |||
PRSS1 | ENST00000463701.1 | n.1005A>G | non_coding_transcript_exon_variant | 2/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 41
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251490Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135916
GnomAD4 exome AF: 0.0000410 AC: 60AN: 1461874Hom.: 1 Cov.: 63 AF XY: 0.0000523 AC XY: 38AN XY: 727238
GnomAD4 genome Cov.: 41
ClinVar
Submissions by phenotype
Hereditary pancreatitis Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2024 | The p.S181G variant (also known as c.541A>G), located in coding exon 4 of the PRSS1 gene, results from an A to G substitution at nucleotide position 541. The serine at codon 181 is replaced by glycine, an amino acid with similar properties. This variant was detected in a child with recurrent acute pancreatitis in conjunction with CFTR p.F508del; the child's healthy mother was also heterozygous for both variants (Corleto VD et al. BMC Gastroenterol, 2010 Oct;10:119). In HEK293 cells, this variant demonstrated similar autoactivation and secretion compared to wild type (Schnúr A et al. Gut, 2014 Feb;63:337-43). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on available evidence to date, the clinical significance of this alteration remains unclear. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2024 | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 181 of the PRSS1 protein (p.Ser181Gly). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with pancreatitis (PMID: 20950468). ClinVar contains an entry for this variant (Variation ID: 571921). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PRSS1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect PRSS1 function (PMID: 23455445). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 20, 2022 | Variant summary: PRSS1 c.541A>G (p.Ser181Gly) results in a non-conservative amino acid change located in the trypsin domain (IPR001254) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 251490 control chromosomes in the gnomAD database, however due to the presence of a highly homologous pseudogene for PRSS1, this finding should be interpreted with caution and allows no conclusion about variant significance. c.541A>G has been reported in the literature in the heterozygous state in a individual affected with acute recurrent pancreatitis, however this individual also had a common pathogenic variant in the heterozygous state in the CFTR gene and had no family history of pancreatitis, including his unaffected mother, who also harbored both variants (e.g. Corleto_2010). Therefore, this report does not provide unequivocal conclusions about association of the variant with Chronic Pancreatitis Risk. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant with respect to protein autoactivation, secretion, and enzymatic activity (e.g. Schnur_2014). One clinical diagnostic laboratory has submitted a clinical-significance assessment for this variant to ClinVar after 2014 and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at